Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC Karin J.C. Sanders, MD, Lizza E. Hendriks, MD, Esther G.C. Troost, MD, PhD, Gerben P. Bootsma, MD, PhD, Ruud M.A. Houben, MSc, Annemie M.W.J. Schols, PhD, Anne-Marie C. Dingemans, MD, PhD Journal of Thoracic Oncology Volume 11, Issue 6, Pages 873-879 (June 2016) DOI: 10.1016/j.jtho.2016.02.013 Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Figure 1 Flowchart detailing the study population. Journal of Thoracic Oncology 2016 11, 873-879DOI: (10.1016/j.jtho.2016.02.013) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Figure 2 Survival analyses. (A) Kaplan Meier overall survival (OS) curve; (B) Kaplan Meier progression-free survival (PFS) curve for patients experiencing early weight loss of more than 5% (solid line) compared with for patients with early weight loss of 5% or less (dotted line). Journal of Thoracic Oncology 2016 11, 873-879DOI: (10.1016/j.jtho.2016.02.013) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Supplemental Data 1 The course of mean (± standard error of the mean) weight loss during therapy of patients experiencing >5% early weight loss (solid line) compared to patients with ≤5% early weight loss (dotted line). Journal of Thoracic Oncology 2016 11, 873-879DOI: (10.1016/j.jtho.2016.02.013) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions